Filed: 2026-04-10 AccNo: 0001628280-26-024716 Size: 16 KB
NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Knight Jeff E.
Filed:
2026-04-17
AccNo:
0001193125-26-161558
Size:
5 KB
发布时间04/17 20:15 UTC
首次发现04/17 20:18 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 476 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001193125-26-161558
Filing Date: 2026-04-17
Accepted: 2026-04-17 16:15:03
Documents: 1
Period of Report: 2026-04-16
ALX ONCOLOGY HOLDINGS INC ( Issuer ) CIK : 0001810182 (see all company filings) EIN. : 850642577 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 4 | ownership.html | 4
1 | 4 | ownership.xml | 4
同簇相关文章
从当前文章回到同一事件簇里的其他来源或补充材料。
1 篇